Skip to main content

Pediatric rheumatology

Browse the latest news, expert commentary, and educational content on pediatric rheumatology.

16-11-2022 | ACR 2022 | Conference coverage | News

JUVE-BASIS: Support for baricitinib in juvenile arthritis

The Janus kinase inhibitor baricitinib has the potential to be “an important part of the treatment landscape” for juvenile arthritis, research suggests.

15-09-2022 | Systemic lupus erythematosus | News

Male sex, older age risk factors for acute kidney abnormalities in childhood SLE

Male sex and older age may put people with childhood-onset systemic lupus erythematosus and nephritis at increased risk for abnormal short-term kidney status, US researchers report.

06-09-2022 | Obesity | News

Childhood adiposity link to PsA, SLE risk ‘may not be fully reversible’

Overweight and obesity during childhood may be associated with an increased risk for systemic lupus erythematosus and psoriatic arthritis that persists even if a healthy bodyweight is achieved during adulthood, researchers report.

Close up of a teenage girl wearing a mask being vaccinated

30-08-2022 | COVID-19 | News

Studies bolster evidence for COVID-19 vaccination in young people with RMDs

Findings from three studies provide further support for the effectiveness and safety of COVID-19 vaccines in young people with rheumatic and musculoskeletal diseases.

17-08-2022 | Spondyloarthropathies | News

Infliximab potential treatment option for juvenile-onset spondyloarthritis

Infliximab appears efficacious for patients with juvenile-onset spondyloarthritis who have failed to respond to conventional treatment, phase 3 study findings show.

11-08-2022 | Guidelines | News

Updated European guidance on vaccination issued for pediatric rheumatology patients

Click through for more details on the EULAR recommendations

11-08-2022 | Psoriatic arthritis | News

Ustekinumab approved for pediatric PsA in the USA

Click through for further information on this expanded indication

01-08-2022 | Lupus nephritis | News

FDA approves belimumab for pediatric lupus nephritis

Click through for more information

30-05-2022 | Juvenile idiopathic arthritis | News

Secukinumab given positive EMA opinion for juvenile arthritis

Click through for further details on this announcement

24-05-2022 | MIS-C | News

MIS-C clinical features largely unchanged since first COVID-19 wave

The incidence and clinical features of multisystem inflammatory syndrome in children were similar during the delta wave of COVID-19 to those observed during the first year of the pandemic among unvaccinated children and adolescents, Danish research suggests.

16-05-2022 | Juvenile idiopathic arthritis | News

Familial autoimmunity may be linked to celiac disease risk in JIA

Individuals with juvenile idiopathic arthritis have a higher-than-average incidence of celiac disease that may be associated with a family history of autoimmunity and a more severe disease course, Italian researchers report.

Lab analysis concept

14-04-2022 | MIS-C | News

IL-1Ra autoantibodies may contribute to MIS-C pathophysiology

Autoantibodies against IL-1Ra are present in a large proportion of patients with MIS-C, say researchers.

22-03-2022 | Juvenile idiopathic arthritis | News

Data support biomarker-guided therapy withdrawal in JIA

Withdrawing therapy on the basis of low levels of high-sensitivity C-reactive protein and the calcium-binding protein S100A12 may be a feasible approach for young people with juvenile idiopathic arthritis in remission, PREVENT-JIA study data show.

Keep up with podcasts on this topic, available on